Cargando…
(1283) Covid-19 Associated Development of Antibody Mediated Rejection in Orthotopic Heart Transplantation Patients
INTRODUCTION: Solid organ transplant candidates encountered increased wait times and mortality rates during the COVID-19 pandemic. Despite improvement in medical management and vaccination efficacy, this patient population remains at increased risk for complications post COVID-19 including organ rej...
Autores principales: | Marek-Iannucci, S., Rajapreyar, I.N., Uber, P., Alvarez, R., Rame, J., Brailovsky, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068086/ http://dx.doi.org/10.1016/j.healun.2023.02.1708 |
Ejemplares similares
-
Natriuretic peptide biomarkers in the imminent development of preeclampsia
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2023) -
Percutaneous Decommissioning 11 Years After Initial CF-LVAD Placement
por: Ruge, Max, et al.
Publicado: (2022) -
Recurrent giant cell myocarditis after heart transplant: a case report
por: Frankel, Eitan S, et al.
Publicado: (2022) -
Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
por: Chih, Sharon, et al.
Publicado: (2012) -
Immune Checkpoint Inhibitor Myocarditis and Cellular Rejection in Orthotopic Heart Transplant Recipients
por: Yeung, Timothy, et al.
Publicado: (2022)